• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Financial incentives improve Hep B vaccination rate among injection drug users

byMelissa McCoyandXiaozhou Liu
April 9, 2014
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Patients undergoing treatment for heroin addiction who received small financial incentives (maximum £30 of supermarket vouchers) were at least 12 times more likely to complete a course of hepatitis B virus (HBV) vaccination than those who received no incentive.

2. At least 80% of participants receiving financial incentives attended appointments on time, ensuring a more efficient use of clinic resources, which may translate into cost-effective practice. 

Evidence Rating Level: 1 (Excellent)      

Study Rundown: High rates of adherence to treatment maximize public health benefits from health interventions. Injecting drug users are at an increased risk for HBV infection and transmission, but adherence to vaccination schedules is poor. This study assessed the effect of providing a small financial incentive (£30 vouchers) to injection drug users completing HBV vaccination. Financial incentive significantly improved adherence to vaccination programs, supporting the implementation of financial incentives in this setting as well as other areas that could potentially benefit from improved appointment adherence such as early antenatal care or tuberculosis testing. Participants were largely representative of patients in opioid substitution programs in the UK, supporting translatability of these findings if this program is scaled-up. Though this study was limited by clinician adherence to some aspects of the intervention (such as failure to explain the schedule and checking understanding of participants) the incentive was correctly given in 96% of appointments.

The study was funded by the UK National Institute for Health Research (RP-PG-0707-10149).

RELATED REPORTS

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

Influenza vaccination may reduce secondary infection spread amongst household contacts

#VisualAbstract: Tenofovir at Gestational Week 16 with HBV Vaccination is Non-inferior to Standard Care in Preventing HBV Transmission

Click to read the study, published today in The Lancet

Relevant Reading: A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

In-Depth [cluster randomized trial]: This study enrolled 210 eligible participants receiving opioid substitution therapy at 12 National Health Service drug treatment services in the UK. Participants received HBV vaccination on days 0, 7, and 21 and were divided into 3 clusters. On-time attendance for vaccination appointments was rewarded with either no incentive (usual treatment), with a fixed financial incentive (3 £10 vouchers), or with an increasing financial incentive (£5, £10, and £15 vouchers). The participants were divided 1:1:1 randomly to one of the 3 clusters.

HBV vaccination within 28 days was the primary outcome and sensitivity analyses examining vaccination completion with full adherence to appointment schedule in a three-month window were also performed. Participants in the clusters receiving financial incentive met the primary outcome measure at much higher rates than did the cluster receiving no financial incentive. 35 (45%) of 78 participants in the fixed incentive cluster met the primary outcome measure (odds ratio 12.1, 95% CI 3.7-39.9; p<0.0001) as did 32 (49%) of 65 participants in the increasing incentive cluster 14.0, 4.2-46.2; p<0.0001) compared to six (9%) of 67 participants treated without such incentives.

More from this author: Minimal association between economic growth and childhood undernutrition for world’s poorest, Nationwide treatment regimen more than halves tuberculosis prevalence in China, Estimated three quarters of people with influenza are asymptomatic [Flu Watch study], Rotavirus vaccine 116E shown effective and affordable in India, Nursing staff cuts associated with increased risk of preventable deaths

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: HBVvaccines
Previous Post

First trimester biomarkers screen for congenital heart defects

Next Post

Spironolactone not beneficial in heart failure with preserved ejection fraction [TOPCAT trial]

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

May 7, 2025
Influenza vaccine not associated with increased risk of epilepsy in children
Infectious Disease

Influenza vaccination may reduce secondary infection spread amongst household contacts

December 1, 2024
#VisualAbstract: Tenofovir at Gestational Week 16 with HBV Vaccination is Non-inferior to Standard Care in Preventing HBV Transmission
StudyGraphics

#VisualAbstract: Tenofovir at Gestational Week 16 with HBV Vaccination is Non-inferior to Standard Care in Preventing HBV Transmission

December 5, 2024
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines

November 17, 2024
Next Post
Spironolactone not beneficial in heart failure with preserved ejection fraction [TOPCAT trial]

Spironolactone not beneficial in heart failure with preserved ejection fraction [TOPCAT trial]

Fibrinolysis for pulmonary embolism may prevent hemodynamic collapse [PEITHO trial]

Fibrinolysis for pulmonary embolism may prevent hemodynamic collapse [PEITHO trial]

RAS mutation linked with survival in metastatic colorectal cancer

Colorectal cancer resection associated with more complications in elderly

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.